All CIRS research papers

7,510 papers, newest first · page 97 of 126

  1. Biochemical origins of the non-monotonic receptor-mediated dose-response

    Journal of Molecular Endocrinology · 2002

  2. Summary of the National Toxicology program’s report of the endocrine disruptors: low-dose peer review

    Environmental Health Perspectives · 2002

  3. Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats

    Toxicological Sciences · 2002

  4. Statistical procedures to test for linearity and estimate threshold doses for tumor induction with nonlinear dose-response relationships in bioassays for carcinogenicity

    Regulatory Toxicology and Pharmacology · 2002

  5. Molecular circuits, biological switches, and nonlinear dose-response relationships.

    Environmental Health Perspectives · 2002

  6. Nonlinear dose response relationships and inducible cellular defence mechanisms

    Journal of Radiological Protection · 2002

  7. What to do at low doses: a bounding approach for economic analysis

    Risk Analysis · 2002

  8. NF-κB, Cytokines, Proteasomes, and Low-Dose Radiation Exposure

    Military Medicine · 2002

  9. Estimating direct effects can be fraught with error if assumptions are made regarding unmeasured confounders for the casual effect of the mediator on the outcome. This paper supports any extrapolation of a one time study in animals extrapolating to long term affects in humans

    Fallibility in estimating direct effects. Int J Epidemiol · 2002

  10. Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro

    Neuroscience Letters · 2002

  11. Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from anIn VitroModel

    Journal of Neuroscience · 2002

  12. Erythropoietin in the central nervous system and its use to prevent hypoxic-ischemic brain damage

    Acta Paediatrica · 2002

  13. Erythropoietin and the brain: from neurodevelopment to neuroprotection

    Clinical Science · 2002

  14. What evidence supports use of erythropoietin as a novel neurotherapeutic? Oncology

    2002

  15. Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up‐regulating Bcl‐xL expression

    Journal of Neuroscience Research · 2002

  16. Hematopoietic factor erythropoietin fosters neuroprotection through novel signal; transduction cascades

    Journal of Cerebral Blood Flow & Metabolism · 2002

  17. Angiogenesis and plasticity: role of erythropoietin in vascular systems

    Journal of Hematotherapy & Stem Cell Research · 2002

  18. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration

    Nature Medicine · 2002

  19. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases

    Circulation · 2002

  20. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt

    Journal of Neuroscience · 2002

  21. Erythropoietin and VEGF exhibit equal angiogenic potential

    Microvascular Research · 2002

  22. Role of Akt signaling in vascular homeostasis and angiogenesis

    Circulation Research · 2002

  23. Participation of the phosphatidylinositol-3-kinase/Akt/endothelial- nitric-oxide synthase signaling in the processes of angiogenesis and vascular remodeling

    Nefrologia · 2002

  24. Transactivation of Vascular Endothelial Growth Factor (VEGF) Receptor Flk-1/KDR Is Involved in Sphingosine 1-Phosphate-stimulated Phosphorylation of Akt and Endothelial Nitric-oxide Synthase (eNOS)

    Journal of Biological Chemistry · 2002

  25. Role of Translation Initiation Factor 2B in Control of Cell Survival by the Phosphatidylinositol 3-Kinase/Akt/Glycogen Synthase Kinase 3β Signaling Pathway

    Molecular and Cellular Biology · 2002

  26. Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome

    Curr Opin Allergy Clin Immunol · 2002

  27. Human CD25+CD4+ T Suppressor Cell Clones Produce Transforming Growth Factor β, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells

    The Journal of Experimental Medicine · 2002

  28. Expression of transforming growth factor β1, transforming growth factor type I and II receptors, and TNF-α in the mucosa of the small intestine in infants with food protein–induced enterocolitis syndrome

    Journal of Allergy and Clinical Immunology · 2002

  29. State of the science on molds and human health

    2002

  30. Levels of household mold associated with respiratory symptoms in the first year of life in a cohort at risk for asthma

    Environmental Health Perspectives · 2002

  31. Indoor Exposure to Mould Allergens

    Archives of Industrial Hygiene and Toxicology · 2002

  32. Indoor dampness and molds and development of adult-onset asthma: a population-based incident case-control study

    Environmental Health Perspectives · 2002

  33. Occurrence of Toxigenic Aspergillus versicolor Isolates and Sterigmatocystin in Carpet Dust from Damp Indoor Environments

    Applied and Environmental Microbiology · 2002

  34. Profiles of airborne fungi in buildings and outdoor environments in the United States

    Nature · 2002

  35. Microbial growth inside insulated external walls as an indoor air biocontamination source

    Applied and Environmental Microbiology · 2002

  36. Isolation and Identification of Aspergillus fumigatus Mycotoxins on Growth Medium and Some Building Materials

    Applied and Environmental Microbiology · 2002

  37. Do indoor molds in nonindustrial environments threaten workers’ health? A review of the epidemiologic evidence

    Epidemiologic Reviews · 2002

  38. Black mold and human illness

    Texas medicine · 2002

  39. Stachylysin May Be a Cause of Hemorrhaging in Humans Exposed to Stachybotrys chartarum

    Infection and Immunity · 2002

  40. Neuropsychological performance of patients following mold exposure

    Applied Neuropsychology · 2002

  41. Role of laminin bioavailability in the astroglial permissivity for neuritic outgrowth

    Anais da Academia Brasileira de Ciências · 2002

  42. Astrocyte-endothelial interactions and blood-brain barrier permeability

    Journal of Anatomy · 2002

  43. Neuro–glia interaction effects on GFAP gene: a novel role for transforming growth factor‐β1

    European Journal of Neuroscience · 2002

  44. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-dr in monocytes during septic shock

    American Journal of Respiratory and Critical Care Medicine · 2002

  45. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients

    Critical Care Medicine · 2002

  46. The immunosuppressive effect of Fusarium mycotoxin as a function of HLA antigens

    Acta Microbiol Immunol Hung · 2002

  47. Ochratoxin Production by the Aspergillus ochraceus Group and Aspergillus alliaceus

    Applied and Environmental Microbiology · 2002

  48. Kinetics of ochratoxin A production in different Aspergillus species

    Acta Biologica Hungarica · 2002

  49. HLA–DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: Frequency, severity, and treatment bias

    Arthritis & Rheumatism · 2002

  50. A functional and structural basis for TCR cross-reactivity in multiple sclerosis

    Nature Immunology · 2002

  51. HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease

    Blood · 2002

  52. HLA‐DQ and DRB1 polymorphism and susceptibility to type 1 diabetes in Jamaica

    European Journal of Immunogenetics · 2002

  53. Susceptibility gene for non-obstructive azoospermia located near HLA-DR and -DQ loci in the HLA class II region

    Human Genetics · 2002

  54. TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjögren's syndrome

    Seminars in Arthritis and Rheumatism · 2002

  55. Faculty Opinions recommendation of Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus.

    Am J Hum Genet · 2002

  56. The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-β

    Journal of Neuroimmunology · 2002

  57. Dendritic Cell Immunogenicity Is Regulated by Peroxisome Proliferator-Activated Receptor γ

    The Journal of Immunology · 2002

  58. IX immunologic tolerance and autoimmunity. WebMD 2002

    2002

  59. Clinical and radiologic manifestations of hypersensitivity pneumonitis

    Journal of Thoracic Imaging · 2002

  60. Characterization of CD3+CD4-CD8- (double negative) T cells in patients with systemic lupus erythematosus: production of IL-4

    Lupus · 2002